NewAmsterdam Pharma Company N.V. (NAMS)
NASDAQ: NAMS · Real-Time Price · USD
18.57
+0.12 (0.65%)
At close: Jun 27, 2025, 4:00 PM
19.30
+0.73 (3.93%)
After-hours: Jun 27, 2025, 4:31 PM EDT
NAMS Market Cap
NAMS has a market cap or net worth of $2.08 billion as of June 27, 2025. Its market cap has increased by 17.73% in one year.
Market Cap
2.08B
Enterprise Value
1.28B
1-Year Change
17.73%
Ranking
Category
Stock Price
$18.57
Market Cap Chart
Since February 8, 2021, NAMS's market cap has increased from $154.45M to $2.08B, an increase of 1,249.87%. That is a compound annual growth rate of 81.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2025 | 2.07B | -24.71% |
| Dec 31, 2024 | 2.75B | 199.19% |
| Dec 29, 2023 | 919.56M | 3.44% |
| Dec 30, 2022 | 889.00M | 537.58% |
| Dec 31, 2021 | 139.43M | -9.72% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 711.28B |
| Johnson & Johnson | 366.40B |
| AbbVie | 327.47B |
| Novo Nordisk | 301.06B |
| UnitedHealth Group | 273.97B |
| Abbott Laboratories | 239.05B |
| Novartis AG | 231.01B |
| AstraZeneca | 216.45B |